Buy Bencogen Tablet Benzotropin Mesylate USP

Bencogen Tablet is a prescription medication containing 2mg of Benztropine Mesylate USP, which belongs to the anticholinergic class of drugs. Manufactured in India, it acts as an antiparkinsonian agent by targeting the central nervous system. The medication works by blocking muscarinic acetylcholine receptors, thereby helping to restore the natural chemical balance between dopamine and acetylcholine in the brain.

Strength

2mg

Pack Size

1000

Storage

Ambient

Manufacturer / TM Owner

Regal Laboratios

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Bencogen Tablet is primarily indicated as an adjunctive therapy in the treatment of all forms of Parkinson's disease, including postencephalitic, arteriosclerotic, and idiopathic variations. It is also widely used to control drug-induced extrapyramidal symptoms (EPS), which are involuntary movement disorders often caused by neuroleptic or antipsychotic medications.

Side Effects

Common side effects of Bencogen Tablet include dry mouth, blurred vision, constipation, nausea, urinary retention, and drowsiness. Some patients, particularly elderly individuals, may experience confusion, memory impairment, or rapid heart rate (tachycardia). Decreased sweating may also occur, which can increase the risk of heat stroke in hot environments.

Precautions & Warnings

Before starting Bencogen Tablet, patients should inform their healthcare provider of any history of glaucoma (especially angle-closure glaucoma), prostatic hypertrophy, urinary retention, or cardiovascular disease. Because it is classified under Pregnancy Category C, it should be used during pregnancy only if the potential benefits outweigh the risks to the fetus. Patients should avoid driving or operating machinery if they experience dizziness or blurred vision.

Avoid Interactions

Bencogen Tablet can interact with other medications that possess anticholinergic properties, potentially worsening side effects like dry mouth, constipation, and urinary retention. Notable interactions include tricyclic antidepressants, monoamine oxidase inhibitors (MAOIs), phenothiazines, and certain antihistamines. Additionally, by slowing gastrointestinal motility, Bencogen may alter the absorption of other co-administered oral medications.

References

Frequently Asked Questions

Published by GNH India Pharmaceuticals Limited

Last updated: 06 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.